Transfer of U.S. rights to Fycompa to Catalyst Pharmaceuticals
A standalone regional rights out-licensing deal under which the U.S. rights to Fycompa are transferred to Catalyst Pharmaceuticals in exchange for an upfront payment and sales-based royalties.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.